Release Date: 28/02/17 09:54 Summary: Half Year Accounts and Appendix 4D Price Sensitive: Yes Download Document 3.39MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%